vs
Side-by-side financial comparison of CareTrust REIT, Inc. (CTRE) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $134.9M, roughly 1.2× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs -82.0%, a 164.5% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs -22.7%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs -11.5%).
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
CTRE vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $134.9M | $164.7M |
| Net Profit | $111.3M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | — | -43.3% |
| Net Margin | 82.5% | -82.0% |
| Revenue YoY | 55.1% | -22.7% |
| Net Profit YoY | 113.5% | -104.8% |
| EPS (diluted) | $0.52 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $134.9M | $164.7M | ||
| Q3 25 | $132.4M | $211.0M | ||
| Q2 25 | $112.5M | $178.9M | ||
| Q1 25 | $96.6M | $1.2B | ||
| Q4 24 | $86.9M | $213.2M | ||
| Q3 24 | $77.4M | $196.8M | ||
| Q2 24 | $68.9M | $186.7M | ||
| Q1 24 | $63.1M | $210.1M |
| Q4 25 | $111.3M | $-135.0M | ||
| Q3 25 | $74.9M | $15.9M | ||
| Q2 25 | $68.5M | $-64.8M | ||
| Q1 25 | $65.8M | $866.6M | ||
| Q4 24 | $52.1M | $-65.9M | ||
| Q3 24 | $33.4M | $-106.7M | ||
| Q2 24 | $10.8M | $-99.2M | ||
| Q1 24 | $28.7M | $-91.6M |
| Q4 25 | — | -43.3% | ||
| Q3 25 | 58.1% | 1.4% | ||
| Q2 25 | 61.3% | -19.5% | ||
| Q1 25 | — | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 43.0% | -27.7% | ||
| Q2 24 | 15.1% | -21.5% | ||
| Q1 24 | — | -21.6% |
| Q4 25 | 82.5% | -82.0% | ||
| Q3 25 | 56.6% | 7.5% | ||
| Q2 25 | 60.9% | -36.3% | ||
| Q1 25 | 68.1% | 73.7% | ||
| Q4 24 | 60.0% | -30.9% | ||
| Q3 24 | 43.2% | -54.2% | ||
| Q2 24 | 15.6% | -53.1% | ||
| Q1 24 | 45.6% | -43.6% |
| Q4 25 | $0.52 | $-1.63 | ||
| Q3 25 | $0.35 | $0.20 | ||
| Q2 25 | $0.35 | $-0.83 | ||
| Q1 25 | $0.35 | $10.04 | ||
| Q4 24 | $0.30 | $-0.85 | ||
| Q3 24 | $0.21 | $-1.39 | ||
| Q2 24 | $0.07 | $-1.29 | ||
| Q1 24 | $0.22 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $198.0M | $1.9B |
| Total DebtLower is stronger | $894.2M | — |
| Stockholders' EquityBook value | $4.0B | $-205.3M |
| Total Assets | $5.1B | $2.9B |
| Debt / EquityLower = less leverage | 0.22× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $198.0M | $1.9B | ||
| Q3 25 | $712.5M | $1.7B | ||
| Q2 25 | $306.1M | $2.0B | ||
| Q1 25 | $26.5M | $2.0B | ||
| Q4 24 | $213.8M | $1.1B | ||
| Q3 24 | $377.1M | $1.0B | ||
| Q2 24 | $495.1M | $1.1B | ||
| Q1 24 | $451.2M | $884.8M |
| Q4 25 | $894.2M | — | ||
| Q3 25 | $893.8M | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $822.1M | — | ||
| Q4 24 | $396.9M | — | ||
| Q3 24 | $396.7M | — | ||
| Q2 24 | $671.1M | — | ||
| Q1 24 | $595.9M | — |
| Q4 25 | $4.0B | $-205.3M | ||
| Q3 25 | $4.0B | $-155.8M | ||
| Q2 25 | $3.3B | $-206.5M | ||
| Q1 25 | $2.9B | $-185.8M | ||
| Q4 24 | $2.9B | $-1.1B | ||
| Q3 24 | $2.4B | $-1.1B | ||
| Q2 24 | $1.9B | $-980.2M | ||
| Q1 24 | $1.7B | $-893.9M |
| Q4 25 | $5.1B | $2.9B | ||
| Q3 25 | $5.1B | $2.6B | ||
| Q2 25 | $4.7B | $2.6B | ||
| Q1 25 | $3.9B | $2.7B | ||
| Q4 24 | $3.4B | $1.7B | ||
| Q3 24 | $2.9B | $1.8B | ||
| Q2 24 | $2.7B | $1.9B | ||
| Q1 24 | $2.3B | $1.8B |
| Q4 25 | 0.22× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.35× | — | ||
| Q1 25 | 0.28× | — | ||
| Q4 24 | 0.14× | — | ||
| Q3 24 | 0.16× | — | ||
| Q2 24 | 0.35× | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $394.0M | $-34.3M |
| Free Cash FlowOCF − Capex | — | $-36.6M |
| FCF MarginFCF / Revenue | — | -22.3% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 3.54× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $394.0M | $-34.3M | ||
| Q3 25 | $100.9M | $-66.3M | ||
| Q2 25 | $100.8M | $-58.3M | ||
| Q1 25 | $71.4M | $870.1M | ||
| Q4 24 | $244.3M | $-30.0M | ||
| Q3 24 | $67.2M | $-77.0M | ||
| Q2 24 | $53.0M | $-71.5M | ||
| Q1 24 | $48.8M | $70.8M |
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
| Q4 25 | 3.54× | — | ||
| Q3 25 | 1.35× | -4.17× | ||
| Q2 25 | 1.47× | — | ||
| Q1 25 | 1.08× | 1.00× | ||
| Q4 24 | 4.68× | — | ||
| Q3 24 | 2.01× | — | ||
| Q2 24 | 4.92× | — | ||
| Q1 24 | 1.70× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
